Early dosing practices and effectiveness of recombinant human erythropoietin-Reference-Cited by-同舟云学术

Early dosing practices and effectiveness of recombinant human erythropoietin

Published:1993-05 Issue:5 Volume:43 Page:1125-1133
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Powe Neil R.,Griffiths Robert I.,Greer Joel W.,Watson Alan J.,Anderson Gerard F.,de Lissovoy Gregory,Herbert Robert J.,Eggers Paul W.,Milam Roger A.,Whelton Paul K.

Publisher

Elsevier BV

Subject

Nephrology

Reference35 articles.

1. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results from a combined phase I and II clinical trial;Eschbach;N Engl J Med,1987

2. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial;Eschbach;Ann Intern Med,1989

3. Recombinant human erythropoietin and renal anemia: Molecular biology, clinical efficacy, and nervous system effects;Nissenson;Ann Intern Med,1991

4. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin;Evans;JAMA,1990

5. Changes in quality of life and functional capacity in hemodialysis patients treated with recombinant human erythropoietin;Laupacis;Semin Nephrol,1990

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemolysis-driven IFNα production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease;Blood Journal;2023-12-20

2. Health Disparities in Nephrology;Brenner and Rector's The Kidney;2012

3. Current Issues in Iron Management in End-Stage Renal Disease;Seminars in Dialysis;2008-06-28

4. Foreword;American Journal of Kidney Diseases;2006-05

5. References;American Journal of Kidney Diseases;2006-05